Post Tagged with: "Biomimetic"

Tennessee Healthcare Company Snubbed First By FDA, Then Investors

Tennessee Healthcare Company Snubbed First By FDA, Then Investors

by / on August 12, 2013

Investors are voicing their displeasure with a Tennessee company, after it failed to get approval for one of its products to be sold in the US. Stock in Wright Medical Group took a pounding when the FDA rejected a clinical trial for its bone graft substitute.

Read more ›

BioMimetic Tries Different Tack for FDA Approval

by / on January 3, 2013

For more than three years, BioMimetic has tried to get Augment approved for use in bone and ankle fusions. The new trial is taking a different approach, testing its effectiveness as a treatment for tendinosis (also known as tennis elbow).

Read more ›

Memphis Company Buys BioMimetic

by / on November 19, 2012

For more than two years, BioMimetic has been working to get the FDA to sign off on Augment. It’s supposed to help the body grow new bone tissue, eliminating the need for bone grafts. The delays have put a financial strain on the company. Earlier this year, it cut a quarter of its staff, leaving about 50 workers.

Read more ›

BioMimetic Continues Trying for Augment Approval

by / on July 9, 2012

Brentwood-based BioMimetic has filed yet another round of paperwork in hopes of gaining federal approval for its bone graft therapy, called Augmentin.

Read more ›

Biotech Firm Lets Workers Go While Waiting For FDA Approval

by / on January 23, 2012

Franklin-based BioMimetic is getting rid of a quarter of its staff.

Read more ›

Biomimetic Ready to Ask for FDA Approval

by / on January 4, 2010

The studies, tests, and research are done. Now, Franklin-based Biomimetic Therapeutics is ready to ask for FDA approval of its only product.

Read more ›

Middle Tennessee Plays Catch Up on Biotech

by / on September 11, 2009

Middle Tennessee has some catching up to do with Memphis and Knoxville in the field of biotechnology.

Read more ›